About
TAZIRA 4.5 GM INJECTION is a combination of two antibiotics. It is used to treat various types of bacterial infections. It fights against the infection by killing the microorganisms.TAZIRA 4.5 GM INJECTION is generally administered by a healthcare professional and should not be self-administered. Depending on the severity of your underlying illness, your doctor will decide the precise dose and schedule as per which this injection is to be given. It is strictly advised to be used as per the doctors prescription.Some of the common side effects of this medicine include nausea, vomiting, diarrhea, and rash. Additionally, you may notice some injection site reactions like pain, swelling, or redness. You should consult your doctor if these side effects do not get better with time and persist for a longer duration.Before using the medicine, you should tell your doctor if you are allergic to any antibiotics or have any kidney or liver problems. Your doctor may change the dose or prescribe a different medicine. This medicine is generally considered safe to use during pregnancy and breastfeeding if used under a doctors supervision. Advanced Antibiotic TherapyTAZIRA 4.5 GM INJECTION combines Ceftriaxone and Tazobactam, delivering broad-spectrum antibiotic action to combat resistant bacterial strains. This dual-action formula is recommended for complex and hospital-acquired infections requiring potent intervention, with proven efficacy when administered under appropriate medical supervision.
Precision in Dosage and AdministrationAdministered intravenously or intramuscularly, TAZIRA is supplied in a convenient powder form for reconstitution by a healthcare professional. Dosage and reconstitution volumes carefully follow physician guidance, ensuring optimal results and minimizing side effects-making it suitable for different age groups and infection profiles.
Safety, Storage, and Shelf LifeWith a shelf life of 24 months from the date of manufacture, this injection must be stored below 25C and protected from light. Medical supervision is essential for both prescription access and proper usage, safeguarding patients and maximizing therapeutic benefits.
FAQ's of TAZIRA 4.5 GM INJECTION:
Q: How is TAZIRA 4.5 GM INJECTION administered to patients?
A: TAZIRA 4.5 GM INJECTION is administered either intravenously or intramuscularly by a qualified healthcare professional, following the reconstitution of the powder with sterile water for injection as directed by the physician or product literature.
Q: What types of infections does TAZIRA 4.5 GM INJECTION treat?
A: This medication is recommended for the treatment of hospital-acquired infections, complicated urinary tract, respiratory tract, intra-abdominal, and skin or soft tissue infections caused by susceptible bacteria.
Q: When should TAZIRA 4.5 GM INJECTION be used?
A: TAZIRA is used when a physician diagnoses severe bacterial infections that require hospitalization or intravenous/intramuscular antibiotic therapy, particularly those not responsive to standard treatments.
Q: Where should TAZIRA 4.5 GM INJECTION be stored before use?
A: Store the unopened vial below 25C in a location protected from direct light to preserve potency and extend shelf life up to 24 months from the date of manufacture.
Q: What is the process for preparing TAZIRA 4.5 GM INJECTION for administration?
A: A healthcare professional reconstitutes the white to off-white powder with sterile water for injection, using the volume specified in the product literature or prescribed by the physician prior to administration.
Q: What are the benefits of using the combination of Ceftriaxone and Tazobactam in TAZIRA?
A: This combination enhances the spectrum of antibacterial activity, enabling effective treatment of infections caused by resistant pathogens, thereby improving patient outcomes in serious bacterial disease settings.
Q: Is TAZIRA 4.5 GM INJECTION suitable for both adults and children?
A: Yes, TAZIRA can be prescribed for both adults and children; however, dosages are determined individually by the physician according to age, weight, and infection severity.